Biological E. Pipeline
| Drug | Indication | Phase |
|---|
| BETD | Diphtheria and Tetanus | Commercial |
| Bett | Tetanus | Commercial |
| BEVAC | Hepatitis B | Commercial |
| COMBEFIVE | Pentavalent (DTwP‑rHepB‑Hib) | Commercial |
| CORBEVAX | SARS‑CoV‑2 (COVID‑19) | Commercial |
| HAPIBEV | Hepatitis A | Commercial |
| HIBE | Haemophilus influenzae type b | Commercial |
| JEEV | Japanese Encephalitis | Commercial |